Skip to main content

Table 2 Primary efficacy evaluation

From: Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial

 Treatment groupP value
GXST (n = 143)Placebo (n = 144)
Angina attack frequency (times/week)
 Before treatment9.4 ± 3.29.0 ± 3.00.44
 After 4-week treatment2.5 ± 1.77.5 ± 2.20.02
Highly effective36 (25.2%)18 (12.5%)0.005
Effective73 (51.0%)48 (33.3%)0.002
No efficacy34 (23.8%)78 (54.2%)< 0.001
  1. Each value represents the number (%)
  2. GXST, Guanxinshutong capsule